Theratechnologies (TSE:TH) Shares Cross Below Two Hundred Day Moving Average of $2.03

Theratechnologies Inc. (TSE:THGet Free Report)’s stock price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$2.03 and traded as low as C$1.78. Theratechnologies shares last traded at C$1.79, with a volume of 7,664 shares.

Theratechnologies Stock Down 1.1 %

The company has a quick ratio of 0.64, a current ratio of 1.15 and a debt-to-equity ratio of 562.07. The firm has a fifty day moving average of C$1.83 and a 200-day moving average of C$2.03. The firm has a market cap of C$81.38 million, a P/E ratio of -2.24, a price-to-earnings-growth ratio of -8.50 and a beta of 1.81.

Theratechnologies (TSE:THGet Free Report) last announced its quarterly earnings results on Wednesday, April 10th. The company reported C($0.13) EPS for the quarter. The firm had revenue of C$21.85 million during the quarter. Theratechnologies had a negative net margin of 23.04% and a negative return on equity of 1,116.86%. On average, equities research analysts anticipate that Theratechnologies Inc. will post 0.0300452 earnings per share for the current year.

About Theratechnologies

(Get Free Report)

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.

Read More

Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with's FREE daily email newsletter.